Pre-Cure utilizes advanced microfluidic technologies which provide versatility for customized tumor-on-a-chip. Instead of using a single measurement, our technology allows parallel measurement of multiple cell functions.
This transforms the tumor-on-a-chip concept to a patient-on-a-chip where the clinical journey is reflected in the best way.
Our technology results from extensive research conducted at the Nanomedicine & Tumor Microenvironment lab at the Hebrew University of Jerusalem led by Prof. Ofra Benny.
Come and explore the future of oncology with Pre-Cure's platform.